XML 73 R57.htm IDEA: XBRL DOCUMENT v3.6.0.2
BUSINESS CONCENTRATIONS (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
Dec. 31, 2016
Sep. 30, 2016
Jun. 30, 2016
Mar. 31, 2016
Dec. 31, 2015
Sep. 30, 2015
Jun. 30, 2015
Mar. 31, 2015
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Concentration Risk [Line Items]                      
Revenues $ 4,487,000 $ 5,536,000 $ 4,403,000 $ 4,930,000 $ 5,630,000 $ 5,190,000 $ 4,848,000 $ 4,475,000 $ 19,356,450 $ 20,142,898 $ 15,026,219
Deferred Revenue [Member]                      
Concentration Risk [Line Items]                      
Concentration Risk                     97.00%
Supplier Concentration Risk [Member]                      
Concentration Risk [Line Items]                      
Concentration Risk                 98.00% 60.00% 82.00%
Customer Concentration Risk [Member] | Sales Revenue [Member] | Woodstock Pharmaceutical and Compounding [Member]                      
Concentration Risk [Line Items]                      
Revenues                 $ 2,247,000 $ 8,848,000 $ 4,054,000
Customer Concentration Risk [Member] | Sales Revenue [Member] | Medical Center Pharmacy [Member]                      
Concentration Risk [Line Items]                      
Revenues                 3,700,000    
Customer Concentration Risk [Member] | Sales Revenue [Member] | Pharmacy Innovations [Member]                      
Concentration Risk [Line Items]                      
Revenues                 $ 2,040,000    
Customer Concentration Risk [Member] | Sales Revenue [Member] | Due West Pharmacy [Member]                      
Concentration Risk [Line Items]                      
Revenues                   $ 4,843,000  
Customer Concentration Risk [Member] | Sales Revenue [Member] | AmerisourceBergen [Member]                      
Concentration Risk [Line Items]                      
Revenues                     1,610,000
Customer Concentration Risk [Member] | Sales Revenue [Member] | McKesson [Member]                      
Concentration Risk [Line Items]                      
Revenues                     1,587,000
Customer Concentration Risk [Member] | Sales Revenue [Member] | Cardinal [Member]                      
Concentration Risk [Line Items]                      
Revenues                     $ 1,804,000
Customer Concentration Risk [Member] | Sales Revenue [Member] | Three Customers [Member]                      
Concentration Risk [Line Items]                      
Concentration Risk                 41.00%    
Customer Concentration Risk [Member] | Sales Revenue [Member] | Three Customers [Member] | Minimum [Member]                      
Concentration Risk [Line Items]                      
Concentration Risk                 10.00%    
Customer Concentration Risk [Member] | Sales Revenue [Member] | Two Customers [Member]                      
Concentration Risk [Line Items]                      
Concentration Risk                   67.00%  
Customer Concentration Risk [Member] | Sales Revenue [Member] | Two Customers [Member] | Minimum [Member]                      
Concentration Risk [Line Items]                      
Concentration Risk                   10.00%  
Customer Concentration Risk [Member] | Sales Revenue [Member] | Four Customers [Member]                      
Concentration Risk [Line Items]                      
Concentration Risk                     75.00%
Customer Concentration Risk [Member] | Sales Revenue [Member] | Four Customers [Member] | Minimum [Member]                      
Concentration Risk [Line Items]                      
Concentration Risk                     10.00%